Early clinical assessment of pneumonia and bronchopneumonia treatment in a Cardiovascular Intensive Care Unit

被引:0
|
作者
Rodriguez Acosta, Andres M. [1 ]
Abilio Luciano, Candido S. [2 ]
Cuellar Perez, Juan C. [1 ]
机构
[1] Hosp Univ Celestino Hernandez Robau, Serv Terapia Intens, Villa Clara, Cuba
[2] Clin Multiperfil, Serv Terapia Intens, Luanda, Angola
来源
CORSALUD | 2015年 / 7卷 / 02期
关键词
Pneumonia; Hospital infection; Anti-bacterial agents; Intensive Care; Hospital costs;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Nosocomial infections are common. Nosocomial pneumonia is the second most common among these infections and is the first in the Intensive Care Unit, where it reaches an incidence of 10-20%. Objective: To determine the effect of progressive clinical assessment from 48-72 hours of initiation of antimicrobial therapy. Method: A descriptive, prospective, cross-sectional research was performed in 57 paoped nosocomial pneumonia or bronchopneumonia and were admitted at the Cardiovascular Intensive Care Unit of Dr. Celestino Hernandez Robau hospital, from January 3 to December 31, 2013. Results: The initial clinical categorization favored the diagnosis of 50 early pneumonia and bronchopneumonia and 7 serious ones. Progressive assessment from 48-72 hours identified the unsatisfactory evolution in 6 (12%) of the early nosocomial pneumonia and in 4 (57.1%) of the serious ones. Conclusions: The early progressive clinical assessment is useful for detecting response to antimicrobial treatment of nosocomial pneumonia and act accordingly.
引用
收藏
页码:130 / 134
页数:5
相关论文
共 50 条
  • [1] Economic impact of new forms of antimicrobial treatment for nosocomial pneumonia in cardiovascular intensive care units
    Rodriguez Acosta, Andres M.
    Cuellar Perez, Juan C.
    Abilio Luciano, Candido S.
    CORSALUD, 2015, 7 (02): : 151 - 153
  • [2] DNA damage assessment in pneumonia patients treated in the intensive care unit
    Dilek Aşci Çelik
    Vehbi Atahan Toğay
    Pınar Karabacak
    Biologia, 2022, 77 : 1909 - 1913
  • [3] DNA damage assessment in pneumonia patients treated in the intensive care unit
    Celik, Dilek Asci
    Togay, Vehbi Atahan
    Karabacak, Pinar
    BIOLOGIA, 2022, 77 (07) : 1909 - 1913
  • [4] Levofloxacin in the treatment of pneumonia in intensive care unit patients
    Alvarez-Lerma, F
    Palomar, M
    Olaechea, P
    León, C
    Sanchez, M
    Bermejo, B
    JOURNAL OF CHEMOTHERAPY, 2004, 16 (06) : 549 - 556
  • [5] Pneumonia in Intensive Care Unit
    Joshi, Vinay
    Mohan, Gurjar
    INDIAN JOURNAL OF ANAESTHESIA, 2008, 52 (02) : 148 - 158
  • [6] Necrotizing pneumonia in intensive care unit
    Correia, Rui Soares
    PAN AFRICAN MEDICAL JOURNAL, 2023, 45
  • [7] Candida Pneumonia in Intensive Care Unit?
    Schnabel, Ronny M.
    Linssen, Catharina F.
    Guion, Nele
    van Mook, Walther N.
    Bergmans, Dennis C.
    OPEN FORUM INFECTIOUS DISEASES, 2014, 1 (01):
  • [8] Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
    Tumbarello, Mario
    De Pascale, Gennaro
    Trecarichi, Enrico Maria
    Spanu, Teresa
    Antonicelli, Federica
    Maviglia, Riccardo
    Pennisi, Mariano Alberto
    Bello, Giuseppe
    Antonelli, Massimo
    INTENSIVE CARE MEDICINE, 2013, 39 (04) : 682 - 692
  • [9] Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients
    Mario Tumbarello
    Gennaro De Pascale
    Enrico Maria Trecarichi
    Teresa Spanu
    Federica Antonicelli
    Riccardo Maviglia
    Mariano Alberto Pennisi
    Giuseppe Bello
    Massimo Antonelli
    Intensive Care Medicine, 2013, 39 : 682 - 692
  • [10] Assessment of severity of intensive care unit-acquired pneumonia and association with aetiology
    Di Pasquale, Marta
    Ferrer, Miquel
    Esperatti, Mariano
    Crisafulli, Ernesto
    Giunta, Valeria
    Li Bassi, Gianluigi
    Blasi, Francesco
    Niederman, Michael S.
    Torres, Antoni
    EUROPEAN RESPIRATORY JOURNAL, 2013, 42